| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1055/S-2007-1004360 |
| P698 | PubMed publication ID | 3883500 |
| P2093 | author name string | Kumar A | |
| Fareed J | |||
| Walenga JM | |||
| Williamson K | |||
| Hoppensteadt DA | |||
| Emanuele RM | |||
| P433 | issue | 1 | |
| P921 | main subject | heparin | Q190016 |
| pharmacokinetics | Q323936 | ||
| P304 | page(s) | 56-74 | |
| P577 | publication date | 1985-01-01 | |
| P1433 | published in | Seminars in Thrombosis and Hemostasis | Q15751825 |
| P1476 | title | Studies on the antithrombotic effects and pharmacokinetics of heparin fractions and fragments | |
| P478 | volume | 11 |
| Q47435172 | Are the current guidelines for the acceptance of generic low molecular weight heparins adequate? |
| Q33411302 | Clinical efficacy of heparin fractions: issues and answers |
| Q39636453 | Drugs that alter the hemostatic mechanism |
| Q44486486 | Efficacy of low-molecular-weight heparin in the management of intermittent claudication |
| Q33673352 | Ex vivo model of an immobilized-enzyme reactor |
| Q28318388 | Heparin pharmacokinetics and pharmacodynamics |
| Q33370169 | Low Molecular Weight Heparins: An Emerging New Class of Glycosaminoglycan Antithrombotics |
| Q43637292 | Low molecular weight heparin-induced liver toxicity |
| Q33348524 | Nadroparin calcium. A review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disorders |
| Q33499002 | Nadroparin calcium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders |
| Q47342595 | The dose proportionality of the pharmacokinetics of ardeparin, a low molecular weight heparin, in healthy volunteers |
Search more.